# Therapeutic Variables in Cataract Surgery

> **NCT00407017** · PHASE4 · COMPLETED · sponsor: **Innovative Medical**

## Conditions studied

- Cataract Surgery

## Interventions

- **DRUG:** Gatifloxacin
- **DRUG:** Ketorolac LS
- **DRUG:** Pred Forte
- **DRUG:** Moxifloxacin
- **DRUG:** Nepafenac
- **DRUG:** EconoPred Plus

## Key facts

- **NCT ID:** NCT00407017
- **Lead sponsor:** Innovative Medical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2007-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00407017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00407017, "Therapeutic Variables in Cataract Surgery". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00407017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*